Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy. J Allergy Clin Immunol, 143(2), 651-661.e9. presented at the 2019 02. doi:10.1016/j.jaci.2018.08.041. (2019).
Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research.. J Allergy Clin Immunol Pract, 6(5), 1534-1544.e5. presented at the 2018 Sep - Oct. doi:10.1016/j.jaip.2018.05.038. (2018).
Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults. J Allergy Clin Immunol, 139(4), 1242-1252.e9. presented at the 2017 Apr. doi:10.1016/j.jaci.2016.08.017. (2017).
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend, 177, 249-257. presented at the 2017 08 01. doi:10.1016/j.drugalcdep.2017.04.020. (2017).
Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy. J Allergy Clin Immunol, 137(4), 1117-1127.e10. presented at the 2016 Apr. doi:10.1016/j.jaci.2015.12.1316. (2016).
Transcriptional Profiling of Egg Allergy and Relationship to Disease Phenotype. PLoS One, 11(10), e0163831. presented at the 2016. doi:10.1371/journal.pone.0163831. (2016).
Oral immunotherapy for treatment of egg allergy in children. N Engl J Med, 367(3), 233-43. presented at the 2012 Jul 19. doi:10.1056/NEJMoa1200435. (2012).
Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies. Transfusion, 49(4), 786-96. presented at the 2009 Apr. doi:10.1111/j.1537-2995.2008.02027.x. (2009).